Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Autoliv Elects President and CEO Mikael Bratt to its Board of Directors

(Stockholm, Sweden, September 20, 2018) – Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, announces that President and CEO Mikael Bratt becomes a member of the Board of Directors of Autoliv, Inc., effective today.On September 20, 2018, Autoliv, Inc. announced that its Board of Directors elected President and CEO Mikael Bratt to become a new member of the Board. The size of the Board has thereby expanded from eight to nine members. Mikael Bratt has been President and CEO of Autoliv since June 29, 2018.Inquiries:Media: Stina Thorman,

Swap drugs for sportswear – workout is the new high

Last week, a revolutionary pop-up shop opened in central Amsterdam, where people could swap drugs for sportswear. Why? Because you don’t need drugs to get high – the same feel-good substances are released in your brain when you work out.It´s the Swedish sports fashion brand Björn Borg that wants to inspire more people to work out and therefore recently launched the concept ”Chase the Exerhighs”, which focuses on the hypnotizing euphoria and joy of exercise. – I believe anyone can agree with us that exercise is better than drugs! It’s amazing how the brain reacts to exercise and how it

Getinge performs a voluntary field correction towards customers on Maquet Cardiosave Intra-Aortic Balloon Pump

Getinge conducts a voluntary field correction globally towards customers of 5,223 Maquet Cardiosave Intra-Aortic Balloon Pumps (IABP) from Datascope Corporation. The costs are expected to be non-material.The voluntary field correction occurs due to potential interruption and/or inability to start therapy to the patient prior to or during the use of Cardiosave IABP for users who are at altitudes above 3,200 feet (975 meters). The costs of the field correction are not material. Communication to customers is carried out in accordance with regulatory processes and requirements, including a

EAB Group Plc: SHARE REPURCHASE 20.9.2018

EAB GROUP Plc          ANNOUNCEMENT           20.9.2018 SHARE REPURCHASE 20.9.2018 In the Helsinki Stock Exchange Trade date 20.9.2018Bourse trade BUYShare EABGBAmount 500 sharesTotal cost 1 694,00 EURAverage price/ share 3,3880 EUR EAB Group Plc now holds a total of 21.343 sharesincluding the shares repurchased on 20.9.2018. On behalf of EAB Group Plc. Nordea Bank AB (publ), Finnish BranchJanne Sarvikivi         Ilari Isomäki Further information:EAB Group Plc Daniel

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 20.09.2018

Fiskars Corporation  NOTIFICATION 20.09.2018 at 18:30 EESTFISKARS CORPORATION: ACQUISITION OF OWN SHARES 20.09.2018 Date 20.09.2018  Exchange transaction Buy  Share class FSKRS  Amount  1 500  Average price/share 17.9702 EURHighest price/share 18.0000 EURLowest price/share 17.9000 EURTotal price 26,955.30 EUR      The shares held by Fiskars Corporation on 20.09.2018:   FSKRS  269,805   On behalf of Fiskars CorporationSkandinaviska

Volvo Buses’ new coach wins Sustainable Bus Award

Volvo Buses has won the Sustainable Bus Award 2019 for the new Volvo 9900 premium coach. The award was conferred at a ceremony during the IAA trade fair in Hannover on 19 September.The award takes into account environmental performance as well as other sustainability aspects such as safety, comfort, noise level, recyclability and the manufacturer’s general environmental performance. “The launch of the new 9900 range represents a real turning point for Volvo. Modern design, improved Cx and new driving area, together with the well-known Volvo Dynamic Steering, are just some of the main new

Ocean Yield ASA: Purchase of shares for the employee incentive program

Reference is made to Ocean Yield ASA’s (“Ocean Yield” or “Company”) stock exchange notice on 20 September 2018 where the Company announced its intention to purchase up to 50,000 treasury shares in connection with its incentive scheme for employees. Ocean Yield has on 20 September 2018 purchased 25,000 shares in the Company on Oslo Stock Exchange at an average price of NOK 63.7326 per share, which implies a total consideration of NOK 1,593,315. The purchase of treasury shares was carried out in accordance with an authorization granted by the Annual General Meeting of the Company on 17 April

Nomination committee appointed in IRLAB

In preparation for the annual general meeting 2019, the company’s three largest shareholders, or groups of shareholders, have appointed members of the nomination committee. The nomination committee consists of Bo Rydlinger, Daniel Johnsson and Olle Stenberg beside Anders Vedin, the chairman of the board. The nomination committee represents almost 58 per cent of shares and votes in the company.According to the instruction for appointment of the nomination committee in IRLAB Therapeutics AB that was resolved at the annual general meeting on May 16, 2018, the nomination committee shall,

Ayima UK Wins New Global Client

Ayima yesterday signed an in initial short-term agreement with a global Payment Processing company, based in the UK and US and listed on the NYSE. The contract is for Search Engine Optimisation (SEO), Training, Paid Social Media, Design and Content Development services on the UK website. The new engagement consists of an initial retainer agreement for a term of 12 months. The value of the contract will be a minimum of approximately 1.2 MSEK in the initial term (at current exchange rates) but is likely to be expanded in the new financial year to cover services for the US side of the

Sale of Rotterdam tank terminal is finalized

Reference is made to the stock exchange announcement of July 2nd 2018, in which Odfjell Terminals entered into an agreement with Koole Terminals B.V. of the Netherlands (Koole) to sell its 100% ownership of Odfjell Terminals Rotterdam (OTR). The sale will generate USD 100 million of cash proceeds to Odfjell. Odfjell announces today that the transaction has closed. For more information: Bjørn Kristian RøedManager Investor Relations & ResearchTel: + 47 55 27 47 33E-mail: bkr@odfjell.com

Redeemed warrants are now registered with the Swedish Companies Registration Office

NextCell Pharma AB ("NXTCL") announced today, 20th September 2018, that the exercised series TO 1 warrants, whose subscription period ended on 13th September 2018, have now been registered with the Swedish Companies Registration Office.A total of 2 720 931 new shares have been registered, which means that the number of shares in NXTCL after registration amounts to 11 226 356. The share capital amounts to SEK 2 301 402.98. Conversion of interim shares to shares is expected to take place on 28th September 2018. Different agents may take a different amount of time to convert, which means that

Internationella Engelska Skolan opening a new school in Solna in 2020

Internationella Engelska Skolan, IES, has signed a lease agreement with Vasakronan to open a new school in the Municipality of Solna from the academic year 2020/21. The operations will be conducted in the Huvudsta area and will cover compulsory school grades 4-9. The initial estimated number of classes is 14, and at capacity, the school will have 30 classes. Annette Brodin Rampe, IES’s CEO commented: ”We want to be part of the solution to the substantial challenges facing schools in Sweden, and at the same time meet the huge demand from municipalities who would like us to open schools in

CLS carries out hands-on workshop at CIRSE in Lisbon, Portugal, 22-25 September 2018

Clinical Laserthermia Systems (CLS) (publ), participates in the CIRSE conference in Lisbon, Portugal, 22-25 September 2018. CLS demonstrates its TRANBERG®|Thermal Therapy System in front of interested physicians and other medical professionals in a hands-on workshop. -   We see a great value in participating in these kind of workshops, where experts in interventional radiology, in an educational format, can get a live experience of the benefits with our product, said Karin Peterson, Chief Product Officer at CLS. The conference of course also provides an excellent opportunity for us to

#18-1697 Listing of Knock out warrants issued by Commerzbank AG

As from September 21, 2018, 3 Knock out warrants issued by Commerzbank AG will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: Commerzbank AG Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from September 21, 2018 and forward or until time for knock out event Market Maker: Commerzbank AG Underlying: DAX 30 Index OMXS30 index Current values of strike and barrier can be found at: [ NGM Market Data Web - KnockOutWarrants ] 

First patient included into ISR’s Phase IIa HIV study

As previously announced, ISR has a Phase IIa study of HIV-infected patients on anti-retroviral therapy (ART), where patients will be randomized to receive GnRH agonist (ISR048) in addition to ART, or ART alone. The first patient is now enrolled.ISR’s Phase IIa clinical study, ISR-003, is conducted at the Karolinska University Hospital Huddinge and at the South Hospital in Stockholm, SÖS. The study is composed of two arms with a total of 26+26 patients to be randomized into ART+ISR048 or to ART alone in the control group. Patients will be treated for 3 months and then followed for an

#18-1696 Listing of Turbo warrants issued by Commerzbank AG

As from September 21, 2018, 2 Turbo warrants issued by Commerzbank AG will be listed on ETP Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: Commerzbank AG Type of security: Call Turbo warrants of European type Execution: Automatic cash settlement Term: As from September 21, 2018 to expiry date Market Maker: Commerzbank AG Underlying: DAX 30 Index OMXS30 index For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20

Asarina Pharma IPO oversubscribed 175%: CEO welcomes new shareholders

With its IPO listing oversubscribed by 175%, Asarina Pharma is firmly in the investor and scientific spotlight. Here, CEO Peter Nordkild shares upcoming research and business highlights with the company’s new shareholders."The major commitments we received from large institutional investors in North America, Europe and Sweden reflect a historic shift in attitudes towards women’s health,” says Asarina Pharma CEO Peter Nordkild. “With a strong hereditary element PMDD has gone untreated and undiagnosed for generations. Our business strategy, combined with the pedigree of our research, means a

Leading Edge Materials Reports Quarterly Results to July 31, 2018

VANCOUVER, BC – September 20, 2018 /CNW/ - Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) announces its third quarter results for the period ending July 31, 2018. All references to dollar amounts in this release are in Canadian dollars. Work undertaken by Leading Edge Materials during the third quarter of 2018 are in line with the Board’s strategic roadmap to support and benefit from the electrification of Europe. Key elements of the Company’s ongoing investment strategy include high value product

Orkla ASA: Issuance of Commercial Paper

Orkla ASA has issued a commercial paper of NOK 350,000,000. Start date:                   24 September, 2018Maturity:                     24 October, 2018Coupon:                      1.05 %Organised by:             DNB Markets Orkla ASAOslo, 20 September 2018 Ref.: Senior Vice President Group TreasuryGeir SolliTel.: +47 995 42 789 This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

#18-1695 Listing of instrument issued by UBS AG

As from September 27, 2018, 1 instrument issued by UBS AG will be listed on Miscellaneous Investment Products MTF SE. The instrument will be registered at Euroclear Sweden AB.Issuer: UBS AG Agent: Strukturinvest For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGM Nordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse

#18-1694 Listing of instrument issued by Investec Bank plc

As from September 27, 2018, 1 instrument issued by Investec Bank plc will be listed on NDX Structured Products Sweden. The instrument will be registered at Euroclear Sweden AB.Issuer: Investec Bank plc Agent: Strukturinvest For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGM Nordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned

Visma to divest retail software units

Visma has entered into an agreement with US private equity firm STG to divest its retail software units to increase the focus on developing as a pure SaaS provider. Visma Retail has increasingly been able to sell its software in new European markets. At the same time, there have been limited synergies with other Visma divisions. The Visma Group focus has been on being a leading regional player in cloud software for both SMB, public sector and enterprise customers. It has become more clear that the group strategies have not been ideal to support the development of Visma Retail Software’s

There are no items matching the current filter
There are no more items matching the current filter
Back to top